Pancreatic Cancer, An Issue of Hematology/Oncology Clinics of North America, E-Book

Description

Approx.240 pages

Key Features

• Contains 14 relevant, practice-oriented topics including diabetes, cachexia, sarcopenia, and metabolic factors in individuals with pancreatic adenocarcinoma; PARP inhibitors and other novel therapeutics in pancreatic adenocarcinoma; screening and surveillance for pancreatic adenocarcinoma in high-risk individuals; germline testing for individuals with pancreatic adenocarcinoma and novel genetic risk factors; and more. 

• Provides in-depth clinical reviews on pancreatic cancer, offering actionable insights for clinical practice. 

• Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. 

Companion Products

• Pancreatic Cancer, An Issue of Hematology/Oncology Clinics of North America

Table of Contents

• View Table of Contents

Author Information

Edited by Matthew B. Yurgelun, MD, Assistant Professor, Medicine, Harvard Medical School, Assistant Professor, Medical Oncology, Dana-Farber Cancer Institute and Douglas A. Rubinson, MD, PhD, Assistant Professor, Medicine, Dana-Farber Cancer Institute and Harvard Medical School